214 related articles for article (PubMed ID: 23109301)
21. Juvenile xanthogranuloma developing after treatment of Langerhans cell histiocytosis: case report and literature review.
Strehl JD; Stachel KD; Hartmann A; Agaimy A
Int J Clin Exp Pathol; 2012; 5(7):720-5. PubMed ID: 22977671
[TBL] [Abstract][Full Text] [Related]
22. Reawakening to the existence of juvenile xanthogranuloma.
Dehner LP
Am J Surg Pathol; 2005 Jan; 29(1):119-20. PubMed ID: 15613865
[No Abstract] [Full Text] [Related]
23. Fetal and neonatal histiocytoses.
Isaacs H
Pediatr Blood Cancer; 2006 Aug; 47(2):123-9. PubMed ID: 16416419
[TBL] [Abstract][Full Text] [Related]
24. Congenital histiocytosis. A heterogeneous group of diseases, one presenting as so-called congenital self-healing histiocytosis.
Kodet R; Elleder M; De Wolf-Peeters C; Mottl H
Pathol Res Pract; 1991 May; 187(4):458-66. PubMed ID: 1908575
[TBL] [Abstract][Full Text] [Related]
25. Juvenile xanthogranuloma with central nervous system lesions.
Flach DB; Winkelmann RK
J Am Acad Dermatol; 1986 Mar; 14(3):405-11. PubMed ID: 3082946
[TBL] [Abstract][Full Text] [Related]
26. A rare case of neonatal systemic xanthogranulomatosis with severe hepatic disease and metachronous skin involvement.
Papadakis V; Volonaki E; Katsibardi K; Stefanaki K; Valari M; Anagnostakou M; Polychronopoulou S
J Pediatr Hematol Oncol; 2012 Apr; 34(3):226-8. PubMed ID: 22031119
[TBL] [Abstract][Full Text] [Related]
27. Disseminated juvenile xanthogranuloma associated with follicular lymphoma in an adult: successful treatment with chemotherapy and rituximab. A review of the literature.
Narváez-Moreno B; Pulpillo-Ruiz Á; De Zulueta-Dorado T; Conejo-Mir J
Actas Dermosifiliogr; 2013 Apr; 104(3):242-6. PubMed ID: 22681714
[TBL] [Abstract][Full Text] [Related]
28. Visual loss with Langerhans cell histiocytosis: multifocal central nervous system involvement.
Job OM; Schatz NJ; Glaser JS
J Neuroophthalmol; 1999 Mar; 19(1):49-53. PubMed ID: 10098549
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.
Nakatani T; Morimoto A; Kato R; Tokuda S; Sugimoto T; Tokiwa K; Tsuchihashi Y; Imashuku S
J Pediatr Hematol Oncol; 2004 Jun; 26(6):371-4. PubMed ID: 15167350
[TBL] [Abstract][Full Text] [Related]
30. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
[TBL] [Abstract][Full Text] [Related]
31. The histopathology of Langerhans cell histiocytosis.
Favara BE; Jaffe R
Br J Cancer Suppl; 1994 Sep; 23():S17-23. PubMed ID: 7521200
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychiatric manifestations in Langerhans' cell histiocytosis disease: a case report and review of the literature.
Mimouni-Bloch A; Schneider C; Politi KE; Konen O; Gothelf D; Stark B; Yaniv I; Shuper A
J Child Neurol; 2010 Jul; 25(7):884-7. PubMed ID: 20595698
[TBL] [Abstract][Full Text] [Related]
33. A Case with Juvenile Xanthogranuloma and Progressive Nodular Histiocytosis Overlap.
Guidolin L; Noguera-Morel L; Hernández-Martín A; Fernández-Llaca H; Rodríguez-Peralto JL; Torrelo A
Pediatr Dermatol; 2017 Mar; 34(2):e102-e103. PubMed ID: 28297144
[TBL] [Abstract][Full Text] [Related]
34. The histiocytoses.
Basset F; Nezelof C; Ferrans VJ
Pathol Annu; 1983; 18 Pt 2():27-78. PubMed ID: 6425790
[No Abstract] [Full Text] [Related]
35. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma.
McClain KL
Clin Perinatol; 2021 Mar; 48(1):167-179. PubMed ID: 33583503
[TBL] [Abstract][Full Text] [Related]
36. Deep juvenile xanthogranuloma: an unusual presentation.
Neveling U; Kahn LB; Valderrama E; Poustchi-Amin M; Uckan D; Shende A
Pediatr Pathol Lab Med; 1997; 17(3):503-11. PubMed ID: 9185228
[TBL] [Abstract][Full Text] [Related]
37. The cutaneous "histiocytoses".
Zelger B; Burgdorf WH
Adv Dermatol; 2001; 17():77-114. PubMed ID: 11758126
[No Abstract] [Full Text] [Related]
38. Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain.
Yamada K; Yasui M; Sawada A; Inoue M; Nakayama M; Kawa K
Pediatr Blood Cancer; 2012 Feb; 58(2):300-2. PubMed ID: 21384540
[TBL] [Abstract][Full Text] [Related]
39. Juvenile xanthogranuloma with presumed involvement of the optic disc and retina.
Hildebrand GD; Timms C; Thompson DA; Atherton DJ; Malone M; Levitt G; Laidlaw DA; Russell-Eggitt I; Taylor DS
Arch Ophthalmol; 2004 Oct; 122(10):1551-5. PubMed ID: 15477475
[No Abstract] [Full Text] [Related]
40. Treatment of juvenile xanthogranuloma.
Stover DG; Alapati S; Regueira O; Turner C; Whitlock JA
Pediatr Blood Cancer; 2008 Jul; 51(1):130-3. PubMed ID: 18338395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
